摘要
目的 了解力克肺疾片抗肺结核的疗效及毒副作用。方法 采用 1DES/ 5DE方案治疗初治Ⅲ型肺结核和结核性渗出性胸膜炎患者共 6 1例 ,并与以 1ERH/ 5ERH方案治疗的 32例进行比较。结果 1DES/ 5DE方案对初治Ⅲ型肺结核和结核性胸膜炎有较好的疗效 ,总有效率达 91.80 % ,疗效与 1ERH/ 5ERH方案相似 (P >0 .0 5 )。两种方案在退热、止咳、减轻毒血症状 ,痰菌阴转时间上疗效亦相仿。前者无明显肝功损害作用。结论 力克肺疾片抗结核治疗疗效确切 ,且无明显肝功损害 。
Objective To evaluate the effect and safety of Dipasic on pulmonary tuberculosis of initial treatment. Methods 61 cases with pulmonary tuberculosis and pleuritis of initial treatment were treated with 1DES/5DE project, while the 1ERH/5 ERH project was adopted to treat 32 cases of control group. The effect and safety were compared between two groups. Results The total valid rate of 1DES/5DE project and 1ERH/5 ERH project was respectively 91.80%and 93.75%( P >0.05) .the effect of reducing fever, relieving coughing, alleviating the toxemia in two groups was similar. The 1DES/5DE project hadn't obvious poison to liver. Conclusion Dipasic has a good effect in anti tuberculosis, and hasn't obvious poison to liver. It can be used in the patients with liver injury
出处
《重庆医学》
CAS
CSCD
2002年第9期802-803,共2页
Chongqing medicine
